MedTrace Logo

A Survey Collecting Data on Adult Height in Patients With Achondroplasia Treated With Somatropin

NCT01435629 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 81

Last updated 2017-05-05

No results posted yet for this study

Summary

This study is conducted in Japan. The aim of the study is to evaluate the efficacy of somatropin (Norditropin®) on adult height (cm) in patients with achondroplasia / hypochondroplasia enrolled in the GH-1941 study (NCT01516229).

Conditions

Interventions

DRUG

somatropin

Dosage and administration to be prescribed by the physician as a result of a normal clinical practice.

Sponsors & Collaborators

Principal Investigators

  • Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-22
Primary Completion
2015-12-04
Completion
2015-12-04

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01435629 on ClinicalTrials.gov